FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

409321002: Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2021. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    3891490011 Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3891491010 Conjugated estrogen 625 microgram and medroxyprogesterone 2.5 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2464772011 Conjugated estrogens 0.625mg/medroxyprogesterone acetate 2.5mg tablet (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    2469117018 Conjugated oestrogens 0.625mg/medroxyprogesterone acetate 2.5mg tablet en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    2469591012 Conjugated estrogens 0.625mg/medroxyprogesterone acetate 2.5mg tablet en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    3486736011 Product containing conjugated estrogens 0.625 mg and medroxyprogesterone acetate 2.5 mg/1 each oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3495077011 Product containing conjugated estrogens 0.625 mg and medroxyprogesterone acetate 2.5 mg/1 each oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3501920012 Conjugated estrogens 0.625 mg and medroxyprogesterone acetate 2.5 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3569924014 Product containing only conjugated estrogens 0.625 mg and medroxyprogesterone acetate 2.5 mg/1 each oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3569925010 Product containing only conjugated estrogens 0.625 mg and medroxyprogesterone acetate 2.5 mg/1 each oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3699573018 Conjugated estrogens 625 microgram and medroxyprogesterone 2.5 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3699574012 Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3699575013 Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3891490011 Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3891491010 Conjugated estrogen 625 microgram and medroxyprogesterone 2.5 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) Is a Estrogens, conjugated+medroxyprogesterone acetate false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. estrogeno false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Medroxyprogesterone (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) Is a Conjugated estrogen- and medroxyprogesterone-containing product false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. estrogènes conjuguès false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Progesterone false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form Conventional release oral tablet (dose form) false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) Is a Product containing medroxyprogesterone in oral dose form (medicinal product form) false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) estrogènes conjuguès false Inferred relationship Existential restriction modifier (core metadata concept) 1
    Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator unit (attribute) mg false Inferred relationship Existential restriction modifier (core metadata concept) 1
    Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value un false Inferred relationship Existential restriction modifier (core metadata concept) 1
    Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) Tablet (unit of presentation) false Inferred relationship Existential restriction modifier (core metadata concept) 1
    Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) Medroxyprogesterone (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 2
    Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator value 2.5 false Inferred relationship Existential restriction modifier (core metadata concept) 2
    Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator unit (attribute) mg false Inferred relationship Existential restriction modifier (core metadata concept) 2
    Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value un false Inferred relationship Existential restriction modifier (core metadata concept) 2
    Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) Tablet (unit of presentation) false Inferred relationship Existential restriction modifier (core metadata concept) 2
    Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Medroxyprogesterone (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 1
    Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) Medroxyprogesterone (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 1
    Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator value 2.5 false Inferred relationship Existential restriction modifier (core metadata concept) 1
    Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. estrogènes conjuguès false Inferred relationship Existential restriction modifier (core metadata concept) 2
    Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) estrogènes conjuguès false Inferred relationship Existential restriction modifier (core metadata concept) 2
    Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator value 0.625 false Inferred relationship Existential restriction modifier (core metadata concept) 2
    Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation Tablet (unit of presentation) false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) Is a Product containing conjugated estrogen and medroxyprogesterone in oral dose form (medicinal product form) false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient estrogènes conjuguès false Inferred relationship Existential restriction modifier (core metadata concept) 1
    Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient Medroxyprogesterone (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 2
    Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient deux false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator value 625 false Inferred relationship Existential restriction modifier (core metadata concept) 1
    Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator unit (attribute) mcg false Inferred relationship Existential restriction modifier (core metadata concept) 1
    Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) Is a Conjugated estrogen and medroxyprogesterone only product in oral dose form false Inferred relationship Existential restriction modifier (core metadata concept)
    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator attribute value reference set (foundation metadata concept)

    REPLACED BY association reference set (foundation metadata concept)

    Back to Start